Ra Pharmaceuticals Signs Merck Deal for Up to $200M

Cambridge, MA-based Ra Pharmaceuticals has signed a collaboration deal with drug giant Merck that could provide the small company with as much as $200 million to support the development of its stable of novel drug candidates. Read the full story